One step membrane incorporation of viral antigens as a vaccine candidate against HIV

Journal of Liposome Research

Volumn 17, Issue 3-4, 2007, Pages 139-154

  Wagner, Andreas ^a,b   Stiegler, Gabriela ^a   Vorauer Uhl, Karola ^a   Katinger, Hermann ^a,b   Quendler, Heribert ^b   Hinz, Andreas ^c   Weissenhorn, Winfried ^c  

^a POLYMUN SCIENTIFIC IMMUNBIOLOGISCHE FORSCHUNG GMBH   (Austria)

^b UNIVERSITY OF AGRICULTURAL SCIENCES   (Austria)

^c EUROPEAN MOLECULAR BIOLOGY LABORATORY   (France)

Author keywords

HIV; Liposomes; Production; Vaccines; Viral antigens

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE; LIPOSOME; RECOMBINANT GLYCOPROTEIN GP 120; RECOMBINANT GLYCOPROTEIN GP 41; UNCLASSIFIED DRUG; VIRUS ANTIGEN;

ANIMAL EXPERIMENT; CONFERENCE PAPER; CONTROLLED STUDY; DRUG FORMULATION; DRUG SYNTHESIS; ENCAPSULATION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION;

AIDS VACCINES; ANIMALS; FEMALE; HIV ANTIGENS; HIV INFECTIONS; HUMANS; MICE; MICE, INBRED BALB C;

EID: 36248987265     PISSN: 08982104     EISSN: 15322394     Source Type: Journal    
DOI: 10.1080/08982100701530159     Document Type: Conference Paper

References (50)

1. Abraham, E., Shah, S. (1992). Intranasal immunization with liposomes containing IL-2 enhances bacterial polysaccharide antigen-specific pulmonary secretory antibody response. J. Immunol. 149:3719-3726.
2. Allison, A. C. (1994). Adjuvants and immune enhancement. Int. J. Technol. Assess. Health Care 10(1): 107-120.
3. Alving, C. R. (1991). Liposomes as carriers of antigens and adjuvants. J. Immunol. Methods 140:1-13.
4. Amorena, B., Baselga, R., Albizu., I. (1994). Use of liposome- immunopotentiated exopolysaccharide as a component of an ovine mastitis staphylococcal vaccine. Vaccine 12:243-249.
5. Anholt, R. R. H. (1988). Functional reconstitution of the olfactory membrane: incorporation of the olfactory adenylate cyclase in liposomes. Biochemistry 27:6464-6468.
6. Anholt, R. R. H., Aebi, U., Pedersen, P. L., Snyder, S. H. (1986). Solubilization and reassembly of the mitochondrial benzodiazepine receptor. Biochemistry 25:2120-2125.
7. Antimisiaris, S. G., Jayasekera, P., Gregoriadis, G. (1993). Liposomes as vaccine carriers Incorporation of soluble and particulate antigens in giant vesicles. J. Immunol. Methods 166:271-280.
8. Bangham, A. D., Standish, M. M., Watkins, J. C. (1965). Diffusion of univalent ions across the lamellae of swollen phospholipids. J. Mol. Biol. 13:238-252.
9. Barenholz, Y., Amselem, S., Lichtenberg, D. (1979). A new method for preparation of phospholipid vesicles (liposomes)-french press. FEBS Lett. 99:210-214.
10. Batzri, S. and Korn, E. D. (1973). Single bilayer liposomes prepared without sonication. Biochim. Biophys. Acta 298:1015-1019.
11. Brandl, M., Bachmann, D., Drechsler, M., Bauer, K. H. (1990). Liposome preparation by a new high pressure homogenizer Gaulin Micron LAB 40. Drug Dev. Ind. Pharm. 16:2167-2191.
12. Brunner, J., Skrabal, P., Hauser, H. (1976). Single bilayer vesicles prepared without sonication. Biochim. Biophys. Acta 455:322-331.
13. Buiting, A. M. J., Van Rooijen, N., Claassen, E. (1992). 44th Forum in Immunology. 541-548.
14. Bülow, R., Boothroyd, J. C. (1991). Protection of mice from fatal Toxoplasma gondii infection by immunization with p30 antigen in liposomes. J. Immunol. 147:3496-3500.
15. Cohen, S., Alonso, M. J., Langer, R. (1994). Novel approaches to controlled-release antigen delivery. Int. J. Technol. Assess. Health Care 10(1):121-130.
16. Deamer, D. and Bangham, A. D. (1976). Large volume liposomes by an ether vaporization method. Biochim. Biophys. Acta 443: 629-634.
17. DeGrip, W. J., Vanoostrum, J., Bovee-Geurts, P. H. (1998). Selective detergent-extraction from mixed detergent/lipid/protein micelles, using cyclodextrin inclusion compounds: a novel generic approach for the preparation of proteoliposomes. Biochem. J. 330:667-674.
18. Driessen, A. J. M., Wickner, W. (1990). Solubilization and functional reconstitution of the protein-translocation enzymes of Escherichia coli. Proc. Natl. Acad. Sci. USA 87:3107-3111.
19. Garcon, N. M. J., Six., H. R. (1991).Universal vaccine carrier: Liposomes that provide T-dependent help to weak antigens. J. Immunol. 146:3697-3702.
20. Glück., R. (1992). Immunopotentiating reconstituted influenza virosomes (IRIVs) and other adjuvants for improved presentation of small antigens. Vaccine 10:915-919.
21. Glück, R., Mischler, R., Brantschen, S., Just, M., Althaus, B., Cryz, S. J. (1992). Immunopotentiating reconstituted influenza virus virosome vaccine delivery system for immunization against hepatitis. A. J. Clin. Invest. 90: 2491-2495.
22. Gregoriadis, G. (1990). Immunological adjuvants: a role for liposomes. Immunol. Today 11:89-97.
23. Grundner, C., Mirzabekov T., Sodroski J., Wyatt, R. (2002). Solid-phase proteoliposomes containing human immunodeficiency virus envelope glycoproteins. J Virol. 76(7):3511-3521.
24. Gupta, R. K., Relyveld, E. H., Lindblad, E. B., Bizzini, B., Ben-Efrain, S., Gupta, C. K. Adjuvants - a balance between toxicity and adjuvanticity. Vaccine 1993, 11:293-306.
25. Huang, C. (1969). Studies on phosphatidycholine vesicles. Formation and physical characterization. Biochemistry 8:344-351.
26. Hui, G. S. N. (1994). Liposomes, muramyl dipeptide derivatives, and nontoxic lipid a derivatives as adjuvants for human malaria vaccines. Am. J. Trop. Med. Hyg. 50:41-51.
27. Jackson, M. L., Litman, B. J. (1982). Rhodopsin-phospholipid reconstitution by dialysis removal of octyl glucoside. Biochemistry 21:5601-5608.
28. Jagodzinski, L. L., Ammann, C., Jager, W., Jacobson, J., Vetter, N., Katinger, H. Antiviral activity of the neutralizing antibodies 2F5 and 2G12 in asymptomatic HIV-1-infected humans: a phase I evaluation. AIDS 2002. 16(15):2019-25.
29. Just, M., Berger, R., Drechsler, H., Brantschen, S., Glück, R. (1992). A single vaccination with an inactivated hepatitis A liposome vaccine induces protective antibodies after only two weeks. Vaccine 10:737-739.
30. Lambert, O., Lévy, D., Ranck, J. L., Leblanc G., Rigaud, J. L. (1998). A new gel-like phase in dodecyl maltoside-lipid mixtures: Implications in solubilization and reconstitution studies. Biophys. J. 74:918-930.
31. Lenz, O., Dittmar, M. T., Wagner, A., Ferko, B., Vorauer-Uhl, K., Stiegler, G., Weissenhorn, W. (2005). Trimeric membrane-anchored gp41 inhibits HIV membrane fusion. J Biol Chem. 280(6):4095-101.
32. Liu, J., Rutz, J. M., Feix, J. B., Klebba, P. E. (1993).Permeability properties of a large gated channel within the ferric enterobactin receptor, FepA. Proc. Natl. Acad. Sci. USA 90:10653-10657.
33. Mayhew, E., Lazo, R., Vail, W. J., King, J., Green, A. M. (1984). Characterization of liposomes prepared using a microemulsifier. Biochim. Biophys. Acta 775:169-174.
34. Milsman, M. H. W., Schwendener, R. A., Weder, H. G. (1978). The preparation of large single bilayer liposomes by a fast and controlled dialysis. Biochim. Biophys. Acta 512:147-155.
35. Muttilainen, S., Idänpään-Heikkilä, I., Wahlström, E., Nurminen, M., Mäkelä, P. H., Sarvas, M. (1995). The Neisseria meningitides outer membrane protein P1 produced in Bacillus subtilisand reconstituted into phospholipid vesicles elicits antibodies to native P1 epitopes. Microb. Pathog. 18:423-436.
36. Olson, F., Hunt, C. A., Szoka, F. C., Vail, W. J., Papahadjopoulos, D. (1979). Preparation of liposomes of defined size distribution by extrusion through polycarbonate membranes. Biochim. Biophys. Acta 557:9-23.
37. Purtscher, M., Trkola, A., Gruber, G., et al. (1994). A broadly neutralizing human monoclonal antibody against gp41 of human immunodeficiency virus type 1. AIDS Res. Hum. Retrovir. 10(12):1651-1658.
38. Reed, L. J., Muench, H. (1938) Am. J. Hygiene 27:493-497.
39. Rhoden, V., Goldin, S. M. (1979). Formation of unilamellar lipid vesicles of controllable dimensions by detergent dialysis. Biochemistry 18:4173-4176.
40. Schurtenberger, P., Mazer, N., Waldvogel, S., Känzig, W. (1984). Preparation of monodisperse vesicles with variable size by dilution of mixed micellar solutions of bile salt and phosphatidylcholine. Biochim. Biophys. Acta 775:111-114.
41. Stahn, R., Schäfer, H., Kunze, M., Malur, J., Ladhoff, A., Lachmann, U. (1992). Quantitative reconstitution of isolated influenza haemagglutinin into liposomes by the detergent method and the immunogenicity of haemagglutinin liposomes. Acta Virol. 36:129-144.
42. Stiegler, G., Armbruster, C., Vcelar, B., Stoiber, H., Kunert, R., Michael, N. L., Stiegler, G., Kunert, R., Purtscher, M., Wolbank, S., Voglauer, R., Steindl, F., Katinger, H. (2001). A potent cross-clade neutralizing human monoclonal antibody against a novel epitope on gp41 of human immunodeficiency virus type 1. AIDS Res. Hum. Retroviruses 17(18):1757-1765.
43. Szoka, F., Papahadjopoulos, D. (1978). Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation. Proc. Natl. Acad. Sci. USA 75:4194-4198.
44. Thérien, H.-M., Lair, D., Shahum, E. (1990). Liposomal vaccine: Influence of antigen association on the kinetics of the humoral response. Vaccine 8:558-562.
45. Tranum-Jensen, J., Christiansen, K., Carlsen, J., Brenzel, G., Vinten, J. (1994). Membrane topology of insulin receptors reconstituted into lipid vesicles. J. Membr. Biol. 140:215-223.
46. Trkola, A., Purtscher, M., Muster, T., et al. (1996). Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1. J. Virology 70:1100-1108.
47. Wagner, A., Vorauer-Uhl, K., Katinger, H. (2002). Liposome produced in a pilot scale: production, purification and efficiency aspects. Eur J Pharm Biopharm 54:213-219.
48. Wagner, A., Vorauer-Uhl, K., Kreismayr, G., Katinger, H. (2002). The crossflow injection technique - an improvement of the ethanol injection method. Journal of Liposome Research 12(3):259-270.
49. Wagner, A., Vorauer-Uhl, K., Kreismayr, G., Katinger, H. (2002). Enhanced protein loading into liposomes by the multiple injection technique. Journal of Liposome Research 12(3):271-283.
50. White, K., Krzych, U., Gordon, D. M., et al. (1993). Induction of cytolytic and antibody responses using Plasmodium falciparum repeatless circumsporozoite protein encapsulated in liposomes. Vaccine 11:1341-1346.